SCHEMBL678102

SCHEMBL678102

CCC(CC(=O)O)C(CC)CC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 1/20 0.45
FFAR3 O14843 2/20 0.44
TDP1 Q9NUW8 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.41
GPR84 Q9NQS5 4/20 0.39
MAPT P10636 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
GABRR1 P24046 2/20 0.38
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5077882 1.00 SLC22A6 (0.45) SLC22A6FFAR3TDP1SMN1; SMN2GPR84
SCHEMBL27945267 0.97 SLC22A6 (0.43) SLC22A6FFAR3TDP1SMN1; SMN2GPR84
SCHEMBL27753421 0.97 SLC22A6 (0.43) SLC22A6FFAR3TDP1SMN1; SMN2GPR84
SCHEMBL17066267 0.89 TDP1 (0.42) SLC22A6FFAR3TDP1SMN1; SMN2GPR84
SCHEMBL9059911 0.87 SLC22A6 (0.42) SLC22A6FFAR3TDP1SMN1; SMN2GPR84
SCHEMBL13403131 0.87 HDAC1 (0.42) SLC22A6FFAR3TDP1GPR84HDAC3
SCHEMBL1572826 0.86 SMN1; SMN2 (0.42) SLC22A6FFAR3TDP1SMN1; SMN2GPR84
SCHEMBL446451 0.86 SLC22A6 (0.46) SLC22A6FFAR3TDP1SMN1; SMN2GPR84
SCHEMBL14359750 0.85 FOLH1 (0.46) FFAR3GPR84HDAC3HDAC1HDAC2
SCHEMBL18222806 0.84 MME (0.39) SLC22A6FFAR3TDP1SMN1; SMN2GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912936-A2 STEREOSELECTIVE SYNTHESIS OF 3,4-DISUBSTITUTED CYCLOPENTANONES AND RELATED COMPOUNDS Pharmacia & Upjohn Company LLC (US) 2008-04-23 EP claimed
WO-2007010387-A2 STEREOSELECTIVE SYNTHESIS OF 3,4-DISUBSTITUTED CYCLOPENTANONES AND RELATED COMPOUNDS PHARMACIA & UPJOHN COMPANY LLC (US) 2007-01-25 WO claimed
US-20230340262-A1 COMPOSITIONS AND ARTICLES COMPRISING BLENDS INCLUDING BRANCHED POLYAMIDE ADVANSIX RESINS & CHEMICALS LLC (US) 2023-10-26 US disclosed
US-9365787-B2 Diesel fuel compositions INNOSPEC LIMITED (GB) 2016-06-14 US disclosed
US-9340691-B2 Hot melt ink composition comprising a copolyester and process for preparing a copolyester OCE-TECHNOLOGIES B.V. (NL) 2016-05-17 US disclosed
EP-2596960-B1 Reusable print medium and method of manufacturing thereof OCE TECH BV (NL) 2016-04-20 EP disclosed
US-20160024373-A1 COMPOUNDS AND METHOD FOR ENHANCED OIL RECOVERY USING SULFUR SURFACTANTS INGEVITY SOUTH CAROLINA, LLC (US) 2016-01-28 US disclosed
US-9127119-B2 Polycarbonate compositions having improved thermal dimensional stability and high refractive index SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2015-09-08 US disclosed
US-8962770-B2 Blends of isosorbide-based copolycarbonate, method of making, and articles formed therefrom SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2015-02-24 US disclosed
US-8809432-B2 Reusable print medium and method of manufacturing thereof OCE TECHNOLOGIES B.V. (NL) 2014-08-19 US disclosed
US-20140174390-A1 DIESEL FUEL COMPOSITIONS INNOSPEC LIMITED (GB) 2014-06-26 US disclosed
US-20110071261-A1 TRANSPARENT ARTICLES PREPARED FROM THERMOPLASTIC COMPOSITIONS HAVING LOW BIREFRINGENCE SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2011-03-24 US disclosed
US-7786246-B2 Isosorbide-based polycarbonates, method of making, and articles formed therefrom SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-08-31 US disclosed
US-20100099832-A1 ISOSORBIDE-BASED POLYCARBONATES, METHOD OF MAKING, AND ARTICLES FORMED THEREFROM SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-04-22 US disclosed
US-7671164-B2 Aliphatic polycarbonates, methods of making, and articles formed therefrom SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-03-02 US disclosed
US-7666972-B2 Isosorbide-based polycarbonates, method of making, and articles formed therefrom SABIC Innovative Plastics IP B., V. (NL) 2010-02-23 US disclosed
US-20090105393-A1 ISOSORBIDE-BASED POLYCARBONATES, METHOD OF MAKING, AND ARTICLES FORMED THEREFROM SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2009-04-23 US disclosed
US-20090105443-A1 ALIPHATIC POLYCARBONATES, METHODS OF MAKING, AND ARTICLES FORMED THEREFROM SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2009-04-23 US disclosed
EP-1912936-A2 STEREOSELECTIVE SYNTHESIS OF 3,4-DISUBSTITUTED CYCLOPENTANONES AND RELATED COMPOUNDS Pharmacia & Upjohn Company LLC (US) 2008-04-23 EP disclosed
WO-2007010387-A2 STEREOSELECTIVE SYNTHESIS OF 3,4-DISUBSTITUTED CYCLOPENTANONES AND RELATED COMPOUNDS PHARMACIA & UPJOHN COMPANY LLC (US) 2007-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024373-A1 COMPOUNDS AND METHOD FOR ENHANCED OIL RECOVERY USING SULFUR SURFACTANTS SRMS, SGMS2, SGMS1 SLC22A6 2138/4885FFAR3 305/4885TDP1 3101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.